PTC Therapeutics, Inc. (PTCT) Social Stream
Ptc Therapeutics Inc (PTCT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Ptc Therapeutics Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 16 months, PTCT's average price target has gone down $3.38.
PTCT reports an average of 42.12% for its upside potential over the past 18 months.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PTCT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 16 months, PTCT's average broker recommendation rating worsened by 0.3.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The variance in analysts' estimates of PTCT is lower than 11.26% of all US stocks.
- Ptc Therapeutics Inc's average analyst price target is greater than 77.4% of Pharmaceutical Products stocks.
- PTCT has a greater upside potential (average analyst target price relative to current price) than 24.7% of Pharmaceutical Products stocks.
- PTCT has a higher number of analysts covering the stock than 72.29% of Pharmaceutical Products stocks.
Is PTCT a Buy, Hold or Sell? See the POWR Ratings now!